# Phase Genomics, Inc. — Form D

Phase Genomics, Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2017-11-22. The offering totals $1.4M, of which $1.0M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2017-11-22
- Form: D
- Accession: 0001722760-17-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.4M
- Amount sold: $1.0M
- Remaining: $400K
- Investors: 4
- Date of first sale: 2017-11-09
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-299384

## Issuer

- Name: Phase Genomics, Inc.
- CIK: 0001722760
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 1617 8th Ave. North, SEATTLE, WA, 98109
- Phone: 206-384-6228

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Shawn Sullivan | Executive Officer | Seattle, WA |
| Shawn Sullivan | Promoter | Seattle, WA |
| Ivan Liachko | Director | Seattle, WA |
| Ivan Liachko | Executive Officer | Seattle, WA |
| Ivan Liachko | Promoter | Seattle, WA |
| Kayla Young | Executive Officer | Seattle, WA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2023-03-21](https://search.stillhousedata.com/formd/0001722760-23-000001) | D | $6.6M | $4.8M |

## More

- [CIK 1722760 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1722760&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001722760-17-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.